Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Disanto

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Journal of Neurology|July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis CohortAlessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
JAMA Neurology|November 6, 2023
Neurofilament Light Chain Elevation and Disability Progression in Multiple SclerosisAhmed Abdelhak, Pascal Benkert, Sabine Schaedelin, et al.
JAMA Neurology|February 6, 2023
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple SclerosisStephanie Meier, Eline A J Willemse, Sabine Schaedelin, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 28, 2023
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis PatientsAlexandra Ramona Todea, Lester Melie-Garcia, Muhamed Barakovic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi StudyÖzgür Yaldizli, Pascal Benkert, Lutz Achtnichts, et al.
Annals of Clinical and Translational Neurology|August 4, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment ResponseMaximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, et al.
The Lancet. Neurology|April 5, 2011
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort studyBrenda Banwell, Amit Bar-Or, Douglas L Arnold, et al.
Bioengineering (Basel, Switzerland)|August 29, 2024
Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric CohortMartina Greselin, Po-Jui Lu, Lester Melie-Garcia, et al.
Brain : a Journal of Neurology|November 14, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosisAleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 19, 2025
Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple SclerosisXinjie Chen, Po-Jui Lu, Mario Ocampo-Pineda, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Journal of Neurology|July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis CohortAlessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
JAMA Neurology|November 6, 2023
Neurofilament Light Chain Elevation and Disability Progression in Multiple SclerosisAhmed Abdelhak, Pascal Benkert, Sabine Schaedelin, et al.
JAMA Neurology|February 6, 2023
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple SclerosisStephanie Meier, Eline A J Willemse, Sabine Schaedelin, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 28, 2023
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis PatientsAlexandra Ramona Todea, Lester Melie-Garcia, Muhamed Barakovic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi StudyÖzgür Yaldizli, Pascal Benkert, Lutz Achtnichts, et al.
Annals of Clinical and Translational Neurology|August 4, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment ResponseMaximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, et al.
The Lancet. Neurology|April 5, 2011
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort studyBrenda Banwell, Amit Bar-Or, Douglas L Arnold, et al.
Bioengineering (Basel, Switzerland)|August 29, 2024
Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric CohortMartina Greselin, Po-Jui Lu, Lester Melie-Garcia, et al.
Brain : a Journal of Neurology|November 14, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosisAleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 19, 2025
Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple SclerosisXinjie Chen, Po-Jui Lu, Mario Ocampo-Pineda, et al.
Pageof 13